Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
about
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlThe role of PIM1/PIM2 kinases in tumors of the male reproductive systemEffect of BRCA1 on epidermal growth factor receptor in ovarian cancer.Productive and Penicillin-Stressed Chlamydia pecorum Infection Induces Nuclear Factor Kappa B Activation and Interleukin-6 Secretion In Vitro.Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity.iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier functionEGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cellsHPV associated tumor cells control tumor microenvironment and leukocytosis in experimental modelsAn IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor responseAdaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals.Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.Alternative Interventions to Prevent Oxidative Damage following Ischemia/ReperfusionNSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.The complexity of NF-κB signaling in inflammation and cancer.Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence.The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.The Unique Molecular and Cellular Microenvironment of Ovarian CancerEpithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment.Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer.HIV Tat protein: Is Tat-C much trickier than Tat-B?Variation and prognostic value of serum plasminogen activator inhibitor-1 before and after chemotherapy in patients with epithelial ovarian cancer.Granulosa cells from emerged antral follicles of the bovine ovary initiate inflammation in response to bacterial pathogen-associated molecular patterns via Toll-like receptor pathways.Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues.Subunit-Specific Role of NF-κB in Cancer.Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer.Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.
P2860
Q26738643-B850EBE7-1933-4626-A299-0E3C1C028499Q26860058-BC51C0F2-3AB3-4FCE-9FAD-27FEE9A0FF62Q28818309-F38CAB68-FC43-4095-A9B0-607A7761E47BQ33643669-67687579-4838-417D-B5C4-6B5AC99D2B2FQ33658962-F6C1AE5B-500C-4709-9FE2-B28CB389DDEAQ33798749-B8C7A6AA-32A4-4196-9CF5-B92047C5566FQ33947954-62F897C9-29CB-4CBF-B3C8-9287D2DF87F0Q34060669-EE03F7BA-81E7-4DCA-B6A9-14C83393FEF0Q34442828-F99BEFB6-FBE1-4135-BE3B-7942E8F2D651Q34868121-B900BA4F-8049-4584-971E-83033E67FF3CQ35264283-AB10D58B-0D32-4854-BE37-4379E6FFFB1BQ35388790-65C65F0F-A566-48B6-962A-9E4F56679C3EQ36214635-622F0D0A-E6E8-48C7-B360-57BCC0DBAD7CQ36358324-0DC4B184-6BDC-4B34-9442-3A635C472FFEQ36412542-2B2001A6-FA92-4677-870A-858BC361F9BAQ36544445-19FF3788-B760-4B91-8EEA-7E24903FF948Q37240714-8A46E297-0D8D-4507-A3E6-22D59C5633E2Q37578724-FC9E386E-AB05-47F2-9191-FD718E5AFC18Q37687793-B0FC0CD4-FE84-4441-9B71-6813B4DC2A77Q38126565-1E164C5D-C600-4A1F-BCD4-AA0A5B8A5208Q38138557-BADE8B6D-EC83-4F48-9DA3-A42DE225F6CFQ38140767-0FABA6F4-0485-4F39-AF30-82E79790F5B3Q38631853-6C744A31-D201-4F44-9732-B9FA3CEBB6E5Q38751253-553BA744-549E-4109-8838-41D33AE41101Q38903238-5838EBA1-48E1-4DF1-89CF-95E30045A355Q39169603-C43B8940-59E0-4B2A-BFB8-56D888921FA7Q39546462-349897A3-6DA5-4F4B-B768-A9462761BC41Q41283473-3524E8C4-5763-40F8-9B50-B76A04878F69Q41329286-9BA8A428-EDB2-428F-8460-6FFE2EB44C22Q43997799-27F99D9E-7D63-4B3D-8B12-B59C1823713BQ44612491-D94CE647-F045-40DE-AF5F-D88ADF822732Q47141937-0BC50A34-8C1C-494D-8D59-67B6CE27DF73Q47573448-B9EC2276-3F0C-4410-B3E8-2B178CE3F0FBQ54115289-FECCFC2E-E8F8-4BAF-90AE-5BA328BFA196Q55311424-58ED325A-30DF-450C-BA22-F26C13CD596CQ55624634-B63326A5-55C9-4A1F-9874-21A1E9B8613B
P2860
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@en
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@nl
type
label
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@en
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@nl
prefLabel
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@en
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Ligand-dependent EGFR activati ...... age epithelial ovarian cancer.
@en
P2093
A Tomassetti
P Pinciroli
S Canevari
P2860
P2888
P304
P356
10.1038/ONC.2011.572
P407
P577
2011-12-12T00:00:00Z
P5875
P6179
1037129887